Somavert (Pfizer Inc) en es it fr

Somavert (Pfizer Inc) Brand names, Somavert (Pfizer Inc) Analogs

Somavert (Pfizer Inc) Brand Names Mixture

  • No information avaliable

Somavert (Pfizer Inc) Chemical_Formula

C990H1532N262O300S7

Somavert (Pfizer Inc) RX_link

http://www.rxlist.com/cgi/generic3/somavert.htm

Somavert (Pfizer Inc) fda sheet

Somavert (Pfizer Inc) msds (material safety sheet)

Somavert (Pfizer Inc) Synthesis Reference

No information avaliable

Somavert (Pfizer Inc) Molecular Weight

22129.0

Somavert (Pfizer Inc) Melting Point

76 oC at pH 3.5 (Gomez-Orellana, I. et al., Protein Sci. 7:1352-1358 (1998).

Somavert (Pfizer Inc) H2O Solubility

No information avaliable

Somavert (Pfizer Inc) State

Liquid

Somavert (Pfizer Inc) LogP

-0.411

Somavert (Pfizer Inc) Dosage Forms

Solution (Subcutaneous Injection); Powder

Somavert (Pfizer Inc) Indication

For treatment of acromegaly

Somavert (Pfizer Inc) Pharmacology

Somavert is used for the treatment of acromegaly, which arises from excessive IGF-1 levels. Somavert selectively binds to growth hormone (GH) receptors on cell surfaces, where it blocks the binding of endogenous GH, and thus interferes with GH signal transduction. Inhibition of GH action results in decreased serum concentrations of insulin-like growth factor-I (IGF-I), and IGF binding protein-3 (IGFBP-3). This reduces the symptoms of acromegaly.

Somavert (Pfizer Inc) Absorption

No information avaliable

Somavert (Pfizer Inc) side effects and Toxicity

No information avaliable

Somavert (Pfizer Inc) Patient Information

BIOD00044.html

Somavert (Pfizer Inc) Organisms Affected

Humans and other mammals